Patients with cancer in the intensive monitoring unit. New perspectives.

Autor: Prieto Del Portillo I; Servicio de Medicina Intensiva, Hospital 12 de Octubre, Madrid, España. Electronic address: iprieto.hrc@salud.madrid.org., Polo Zarzuela M; Servicio de Hematología, Hospital Clínico San Carlos, Madrid, España., Pujol Varela I; Servicio de Medicina Intensiva, Hospital MD Anderson, Madrid, España.
Jazyk: English; Spanish; Castilian
Zdroj: Revista clinica espanola [Rev Clin Esp (Barc)] 2014 Oct; Vol. 214 (7), pp. 403-9. Date of Electronic Publication: 2014 Apr 26.
DOI: 10.1016/j.rce.2014.03.005
Abstrakt: In recent years, there has been a significant improvement in the survival of patients with cancer in intensive care units (ICUs). Advances in medical and surgical treatments and better selection of patients has helped improve the life expectancy of this type of patient. An appropriate and early resuscitation in the ICU, without initial limitations on the life support techniques, has been shown to also decrease the mortality of patients with cancer. At present, we should not deny admission to the ICU based only on the underlying neoplastic disease. However, the mortality rate for patients with cancer in the ICU, especially those with hematologic disease, remains high. In some cases, an ICU admission test (ICU test) is required for at least 3 days to identify patients who can benefit from intensive treatment. We would like to propose a decision algorithm for ICU admission that will help in making decisions in an often complex situation.
(Copyright © 2013 Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: